Joshua Stokar
Jerusalem, JM, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Risk of medication-related osteonecrosis of the jaw during romosozumab treatment.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: April 16, 2026
Risk of significant liver enzyme elevation after switching antithyroid drugs.
Journal: European journal of endocrinology
Published: February 18, 2026
Sclerosing Cholangitis and Multiple Liver Abscesses in a Patient with Thymoma, Myasthenia Gravis, and Immune Deficiency (Good's Syndrome).
Journal: The American journal of case reports
Published: November 17, 2025
Earlier Menopause and Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Global Cohort Study.
Journal: Diabetes/metabolism research and reviews
Published: October 27, 2025
Systematic screening identifies medication and disease factors associated with schizophrenia risk.
Journal: Brain, behavior, and immunity
Published: July 08, 2025
Long-Term Glucagon-Like Peptide 1 Receptor Agonist Use Is Not Associated With Increased Risk of Thyroid Cancer in Adults With Type 2 Diabetes.
Journal: Diabetes/metabolism research and reviews
Published: June 18, 2025
Risk of Suicidal Ideation or Attempts in Adolescents With Obesity Treated With GLP1 Receptor Agonists.
Journal: JAMA pediatrics
Published: October 14, 2024
Response to Letter to the Editor From Kawaguchi: "Cardiovascular Safety of Romosozumab vs PTH Analogs for Osteoporosis Treatment: A Propensity Score Matched Cohort Study".
Journal: The Journal of clinical endocrinology and metabolism
Published: May 08, 2024
Cardiac Left Ventricular miRNA-26a Is Downregulated in Ovariectomized Mice, Upregulated upon 17-Beta Estradiol Replacement, and Inversely Correlated with Collagen Type 1 Gene Expression.
Journal: International journal of molecular sciences
Published: March 30, 2024
Low ALT Is Associated with IBD and Disease Activity: Results from a Nationwide Study.
Journal: Journal of clinical medicine
Published: March 04, 2024
Cardiovascular Safety of Romosozumab vs PTH Analogues for Osteoporosis Treatment: A Propensity-Score-Matched Cohort Study.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 15, 2024
Last Updated: 09/26/2026